A Cortelezzi
Overview
Explore the profile of A Cortelezzi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
455
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
San Juan M, Lavarias S, Aparicio V, Larsen K, Colman Lerner J, Cortelezzi A
Chemosphere
. 2022 Dec;
313:137598.
PMID: 36549510
After their application in agricultural areas, pesticides are dispersed throughout the environment, causing contamination problems. In Argentina, the main promoter of transgenic biotechnology in the region, the total consumption of...
2.
Greenfield D, Salooja N, Peczynski C, van der Werf S, Schoemans H, Hill K, et al.
Bone Marrow Transplant
. 2021 Jul;
56(11):2820-2825.
PMID: 34274955
Metabolic syndrome (MetS) is associated with cardiovascular disease in the general population and is also a potential cardiovascular risk factor in survivors of haematopoietic cell transplantation (HCT). We report an...
3.
Domingo-Domenech E, Duarte R, Boumedil A, Onida F, Gabriel I, Finel H, et al.
Bone Marrow Transplant
. 2021 Jan;
56(6):1391-1401.
PMID: 33420392
Background: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option in advanced-stage mycosis fungoides (MF) and Sézary syndrome (SS). This study presents an updated analysis of the...
4.
San Juan M, Cortelezzi A, Albornoz C, Landro S, Arrighetti F, Najle R, et al.
Ecotoxicol Environ Saf
. 2020 Apr;
196:110565.
PMID: 32272347
The aim of the present work was to study the effect of the pyrethroid cypermethrin (CYP) on the non-target freshwater snail Chilina parchappi. Initially, the sensitivity of adult snails to...
5.
Reda G, Cassin R, Gentile M, Mauro F, Giannarelli D, Fattizzo B, et al.
Leukemia
. 2019 Jan;
33(6):1519-1522.
PMID: 30635629
No abstract available.
6.
Voso M, Leone G, Piciocchi A, Fianchi L, Santarone S, Candoni A, et al.
Ann Oncol
. 2017 Apr;
28(7):1547-1553.
PMID: 28368509
Background: Allogeneic stem-cell transplantation (HSCT) is the only curative treatment in myelodysplastic syndromes (MDS). Azacitidine (AZA) is increasingly used prior to HSCT, however in Europe it is only approved for...
7.
Ronchetti D, Manzoni M, Agnelli L, Vinci C, Fabris S, Cutrona G, et al.
Blood Cancer J
. 2016 Sep;
6(9):e468.
PMID: 27611921
Long non-coding RNAs (lncRNAs) represent a novel class of functional RNA molecules with an important emerging role in cancer. To elucidate their potential pathogenetic role in chronic lymphocytic leukemia (CLL),...
8.
Del Papa N, Onida F, Zaccara E, Saporiti G, Maglione W, Tagliaferri E, et al.
Bone Marrow Transplant
. 2016 Aug;
52(1):53-58.
PMID: 27548467
We retrospectively evaluated the efficacy of autologous hematopoietic stem cell transplantation (AHSCT) in 18 patients with rapidly progressive diffuse cutaneous systemic sclerosis (rp-dcSSc), and compared their disease outcomes with those...
9.
Reda G, Orofino N, Cassin R, Sciume M, Fattizzo B, Cortelezzi A
Expert Opin Drug Saf
. 2016 Mar;
15(6):865-73.
PMID: 26967902
Introduction: Obinutuzumab is a novel glycoengineered type II anti-CD20 monoclonal antibody (MoAb) with a higher affinity for CD20 epitope. It was approved by the United States Food and Drug Administration...
10.
Gentile M, Shanafelt T, Cutrona G, Molica S, Tripepi G, Alvarez I, et al.
Leukemia
. 2015 Dec;
30(6):1440-3.
PMID: 26648537
No abstract available.